Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback | Eiger BioPharmaceuticals
The Investor Relations website contains information about Eiger BioPharmaceuticals’s business for stockholders, potential investors, and financial analysts.